Related references
Note: Only part of the references are listed.Causes and pathogenesis of focal segmental glomerulosclerosis
Agnes B. Fogo
NATURE REVIEWS NEPHROLOGY (2015)
Focal Segmental Glomerulosclerosis Recurrence in the Renal Allograft
Nicolae Leca
ADVANCES IN CHRONIC KIDNEY DISEASE (2014)
Treatment of FSGS in Children
Christine B. Sethna et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2014)
The Landscape of Clinical Trials in Nephrology: A Systematic Review of ClinicalTrials.gov
Jula K. Inrig et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Adaptive Clinical Trial Design
Shein-Chung Chow
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation
Marianne Delville et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Patient Recruitment into a Multicenter Randomized Clinical Trial for Kidney Disease: Report of the Focal Segmental Glomerulosclerosis Clinical Trial (FSGS CT)
Maria Ferris et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2013)
Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research
Naihua Duan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome
Kristen Sgambat et al.
PEDIATRIC NEPHROLOGY (2013)
Circulating suPAR in Two Cohorts of Primary FSGS
Changli Wei et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
New players in the pathogenesis of focal segmental glomerulosclerosis
Christoph Schell et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Risk of Mortality, Fatal Infection, and Fatal Malignancy Related to Use of Anti-Tumor Necrosis Factor-α Biologics by Rheumatoid Arthritis Patients
Veena Thyagarajan et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2012)
Focal Segmental Glomerulosclerosis and Chronic Kidney Disease in Pediatric Patients
Jeremy Kiffel et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2011)
Clinical trial of focal segmental glomerulosclerosis in children and young adults
Debbie S. Gipson et al.
KIDNEY INTERNATIONAL (2011)
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
Changli Wei et al.
NATURE MEDICINE (2011)
Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design
Howard Trachtman et al.
BMC NEPHROLOGY (2011)
Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group
Melanie S. Joy et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Circulating Permeability Factors in Idiopathic Nephrotic Syndrome and Focal Segmental Glomerulosclerosis
Ellen T. McCarthy et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy
Eric De Smet et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity
Virginia J. Savin et al.
TRANSLATIONAL RESEARCH (2008)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
T Bongartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Differential risk of remission and ESRD in childhood FSGS
DS Gipson et al.
PEDIATRIC NEPHROLOGY (2006)
Focal and segmental glomerulosclerosis: Definition and relevance of a partial remission
S Troyanov et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
The number, quality, and coverage of randomized controlled trials in nephrology
GFM Strippoli et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Share Paper
